Bearish flow noted in Neumora Therapeutics (NMRA) Inc with 6,521 puts trading, or 9x expected. Most active are Jan-25 5 puts and Jan-25 7.5 puts, with total volume in those strikes near 5,900 contracts. The Put/Call Ratio is 6.25, while ATM IV is up nearly 29 points on the day. Earnings are expected on March 6th.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NMRA:
- Neumora Therapeutics Inc put volume heavy and directionally bearish
- J&J trial news may have positive read for Neumora Therapeutics, says RBC Capital
- Neumora Therapeutics Reports Q3 2024 Financial Results
- Neumora Therapeutics reports Q3 EPS (45c), consensus (39c)
- Neumora Therapeutics downgraded to Neutral from Overweight at JPMorgan
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue